
How to Prevent and Treat Hair Loss
Check in With Your Dermatologist
A doctor will help you narrow down which type of hair loss you're dealing with. 'More than 50 percent of the time, we can nail the diagnosis based on the patient's health history and examining the scalp and hair,' says Angela Lamb, a New York-based dermatologist. From there, you can discuss whether medications make sense for you. Minoxidil, a topical or oral treatment, is often the first line of defense for androgenetic alopecia hair loss (caused by aging, genetics and hormones), while telogen effluvium (brought on by stressors like sickness or a life change) are typically resolved by managing your triggers.
Get Your Scalp in Shape
For most types of hair loss and thinning, proper care starts at the scalp. These are some of the most effective professional and at-home treatments that can help with issues like inflammation or irritation:
Platelet-rich plasma therapy involves a medical professional injecting a concentrated version of your own blood into your scalp, to potentially stimulate dormant follicles. PRP tends to be best for androgenetic alopecia, says Lamb, but can sometimes also speed up recovery from stress-related hair loss.
Near-infrared lasers can reduce inflammation and spur activity in the follicles, slowing hair loss and improving hair quality after a few months. You can use either a head cap or a hand-held comb at home two to three times a week for eight to 20 minutes per session. Consistency is key with these devices, and the Boston-based dermatologist Maryanne Makredes Senna notes that combs are easier to maneuver. F.D.A.-approved models include Hairmax's Ultima Classic LaserComb and Theradome's Pro LH80.
Microneedling the scalp triggers a wound-healing response, which can encourage hair growth. It also enhances the absorption of other ingredients like minoxidil or PRP. Though you can find at-home microneedling tools (such as dermarollers or dermapens), the professional-level devices used by dermatologists have longer needles for better results.
Whether or not you try in-office therapies, practice good scalp care: Don't overwash your hair (one to three times a week is generally best, depending on your hair type), go light with styling products at your roots to avoid buildup and run any major changes to your scalp health (such as redness, flakes or irritation) by your doctor.
Be Cautious of Supplements
Certain deficiencies — such as in vitamin D, iron and protein — can stunt hair growth. But before stocking up on supplements, talk to your doctor; most adults can get adequate nutrients through their diet or a daily multivitamin, according to Lamb. Be wary of ultra-potent supplements marketed specifically for hair loss, which are unregulated and potentially harmful. 'High doses of biotin can disrupt thyroid levels, for example, and high doses of B vitamins can cause acne,' says Lamb. Focus instead on reducing stress and chronic inflammation, common triggers that, if left unchecked, can accelerate hair loss.
Want all of The Times? Subscribe.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Starbucks tests coconut drinks, agave syrup in healthier menu for RFK Jr. era
(Bloomberg) — Starbucks Corp., (SBUX) which built a loyal following in part by selling sugary candy-colored drinks, has a vision for a healthier menu that's better suited for the MAHA era. It's testing matcha and cold brew made with coconut water. It's exploring syrups sweetened with agave instead of sugar. It's been piloting a protein-infused cold foam and looking into more plant-based products. The moves are meant to draw in the health and wellness crowd, part of a broader menu overhaul designed to bring more traffic to stores and reverse a stubborn sales slump. On Tuesday, the company reported its sixth straight quarter of same-store sales declines and a steeper-than-expected drop in profits. The menu revamp is one element of a turnaround plan put into place by Chief Executive Officer Brian Niccol that has yet to bear fruit. 'We've been working on sugar reduction,' Dana Pellicano, who leads product development at Starbucks, said in an interview. This week, the Seattle-based chain started testing coconut-water-based beverages at five New York-area stores. The drinks have about a third of the sugar content of a summer-berry lemonade refresher, plus electrolytes. A bigger regional test will soon follow. As the chain builds out its new menu, sugar is a key area of focus, Pellicano said. The company is exploring syrups made with sweeteners such as agave, dates or coconut and 'actively working on' other sugar-free beverages, Pellicano said. Earlier this year, the chain launched lower-calorie ready-made Frappuccinos and sugar-free canned energy drinks. It also removed sweetener from its matcha powder. Starbucks is walking a fine line. Its sugar-laden Frappuccinos and refreshers bring much-needed traffic to stores, but the chain also wants to appeal to a growing cohort of health-conscious customers. US Health and Human Services Secretary Robert F. Kennedy, Jr. put a spotlight on the company when he said that CEO Niccol pledged that Starbucks would 'further MAHA' its menu. The focus on adding healthier options predates the Trump administration, according to Pellicano. The company removed ingredients such as high-fructose corn syrup, as well as artificial dyes and flavors, years ago. It launched the sugar-free matcha in January, before Kennedy was confirmed to his post. The strategy, Pellicano said, is to offer more options to draw a variety of customers. For people on weight-loss shots or on a diet, Starbucks is looking into more nutrient-dense foods, like that protein foam. It's planning vegetarian, vegan and gluten-free options. Any new new food or drink items it launches will start with a test in five US stores. From there, baristas and customers can give feedback on everything from taste to how difficult products are to make. If it's successful, a wider release will follow. 'We are the industry leader in customization,' she said, adding that Starbucks wants customers to find something on its menu 'without having to sacrifice how they want to feel about their choices.' (Adds information from company's earnings in fourth graf. ©2025 Bloomberg L.P.
Yahoo
2 hours ago
- Yahoo
Optometrist Dr. Selina McGee Highlights the Dry Eye Epidemic and New Skincare Solutions with YourUpdateTV
Dr. Selina McGee Teams with OPTASE to Discuss the Warning Signs of Dry Eye Disease and Treatment Options NEW YORK, July 30, 2025 (GLOBE NEWSWIRE) -- Dry eye disease affects millions and is increasingly driven by prolonged screen time, dry indoor environments, and everyday beauty products that can inadvertently irritate or damage the eyes. Nearly half of Americans experience symptoms such as stinging, burning, fluctuating vision, or gritty eyes, often dismissing them as normal fatigue. Untreated dry eyes can progress to inflammation, damage to the eye's surface, and even long-term issues with tear production. Recently, Optometrist and Founder of Bespoke Vision, Dr. Selina McGee teamed up with OPTASE on a nationwide media tour to discuss the warning signs for dry eyes and treatment options that can help. One of the most overlooked triggers of dry eye is screen time. Prolonged staring at screens reduces both the frequency and completeness of blinking, disrupting the tear film and accelerating evaporation. Combined with dry indoor air or air conditioning, this can lead to persistent eye discomfort throughout the day. Dr. McGee also highlighted the impact of makeup and skincare products on eye health. Many common formulations contain preservatives, synthetic fragrances, or surfactants that can migrate into the eyes, exacerbating dryness and inflaming the glands responsible for keeping them lubricated and comfortable. For gentle daily care, Dr. McGee recommended the OPTASE® LIFE product line, designed specifically for dry and sensitive skin around the eyes. The Sensitive Eye Makeup Remover features just seven ingredients—including Ionized Water, Hyaluronic Acid, Panthenol, and Manuka Honey—to cleanse thoroughly without irritating the eye area. The Sensitive Eye Daily Renewal Cream contains 13 ingredients, including Glycerin and Vitamin E, and offers 48 hours of hydration while helping restore the skin's natural barrier and reducing the appearance of fine lines. For daytime relief, OPTASE® Intense Drops provide fast-acting, preservative-free moisture, ideal for long workdays or extended digital use. All products are available at with 20% off OPTASE® LIFE products using the code LIFE20 at checkout. About Dr. Selina McGee:Dr. Selina McGee, OD, FAAO, is a nationally acclaimed optometrist and the founder of BeSpoke Vision in Edmond, Oklahoma. Known for her expertise in dry eye disease, aesthetics, and ocular surface health, Dr. McGee blends advanced medical training with a personalized, patient-first approach to eye care. She is a Fellow of the American Academy of Optometry and serves on numerous professional advisory boards. Dr. McGee is passionate about educating patients and providers alike on the impact of lifestyle, beauty routines, and technology on long-term eye health. * YourUpdateTV is a property of D S Simon Media. The video included and release was part of a media tour that was produced by D S Simon Media on behalf of OPTASE. Dante MuccigrossoDirector of Media Integration & Client ReportingE: dantem@ 973.524.0104 A video accompanying this release is available at
Yahoo
2 hours ago
- Yahoo
UPDATE - Axonius Acquires Medical Device Security Specialist Cynerio for More Than $100 Million to Target Healthcare Market
Move enables $2.6 billion cybersecurity unicorn to secure connected medical devices and protect patient care NEW YORK, July 30, 2025 (GLOBE NEWSWIRE) -- Axonius, the global leader in cyber asset intelligence, today announced that it has acquired Cynerio, a pioneer in medical device security for more than $100 million in a cash and stock transaction. The acquisition looks to address a critical challenge for healthcare providers, where the proliferation of connected medical devices has created a vast and unprotected attack surface. These specialized assets, essential to patient care, have historically been invisible to traditional security tools, creating significant risk to both patient safety and hospital operations. 'Hospitals have been operating with a massive digital security blind spot,' said Dean Sysman, co-founder and CEO, Axonius. 'The very devices essential for patient care, from infusion pumps to MRI machines, have been completely invisible to cybersecurity teams, creating a dangerous, unprotected attack surface. This acquisition will help end that.' Sysman added, 'By integrating Cynerio's deep clinical expertise with Axonius asset intelligence, we can offer healthcare providers what they've been asking for: a single source of truth capable of securing their entire clinical environment.' 'In today's healthcare environments, risk doesn't respect the boundaries between clinical and enterprise systems. The combination of Cynerio's specialized medical device context with Axonius' foundational asset intelligence addresses this challenge directly," said Rasu Shrestha, MD, MBA, EVP and Chief Innovation and Commercialization Officer at Advocate Health, and Chairman of the Board at Cynerio. "It provides the holistic visibility required to manage the entire connected attack surface, enabling healthcare organizations to build more resilient security programs. This is a vital step forward in helping ensure technology can securely and effectively support the core mission of patient care.'Today's news represents a significant shift in the healthcare cybersecurity landscape. The acquisition was driven by a shared understanding that securing medical devices in a silo is no longer sufficient. Both companies recognized a growing customer demand for a single, unified platform to manage and secure the entire clinical environment—from traditional IT infrastructure to connected medical devices. By combining Axonius' asset intelligence platform with Cynerio's deep medical device expertise, the company is positioned to meet the immediate needs of hospitals while setting the foundation for broader Cyber-Physical Systems (CPS) security. As part of the acquisition, Cynerio co-founder and CEO, Leon Lerman, will join Axonius as senior vice president. Co-founder Daniel Brodie will join the Office of the CTO. The Cynerio team joins Axonius to accelerate the company's expansion into the healthcare market. Additional terms of the transaction were not disclosed. Read more about 'The Hidden Side of Healthcare: Why We're Acquiring Cynerio' in a blog post by Dean Sysman, co-founder and CEO, Axonius. About Cynerio:Cynerio has one simple goal—to secure every medical device in healthcare environments. With capabilities ranging from microsegmentation and improved device insight to identifying exposed ePHI and stopping ransomware, Cynerio provides the technology and expertise needed to protect hospitals from a variety of cyberattacks. About Axonius:Axonius transforms asset intelligence into intelligent action. With the Axonius Asset Cloud, customers preemptively tackle high-risk and hard-to-spot threat exposures, misconfigurations, and overspending. The integrated platform brings together data from every system in an organization's IT infrastructure to optimize mission-critical risk, performance, and cost measures via actionable intelligence. Covering cyber assets, software, SaaS applications, identities, vulnerabilities, infrastructure, and more, Axonius is the one place to go for Security, IT, and GRC teams to continuously drive actionability across the organization. Cited as one of the fastest-growing cybersecurity startups, with accolades from CNBC, Forbes, and Fortune, Axonius supports millions of assets for leading customers across industries and around the world. Bring truth to action with Axonius. Learn more at Media Contact: press@ A photo accompanying this announcement is available at